Literature DB >> 27538522

Elevated level of circulating CD4+Helios+FoxP3+ cells in primary Sjogren's syndrome patients.

Chen Liu1, Zhao Guan1, Lei Zhao1, Ying Song1, Hui Wang1.   

Abstract

OBJECTIVE: This study was designed to investigate the expression of regulatory T cells in primary Sjögren's Syndrome (pSS) and to evaluate the clinical role of CD4 + Helios+ FoxP3+ cells in pSS patients.
METHODS: CD4 + FoxP3+ T cells in the peripheral blood of 39 pSS patients and 30 healthy controls were measured by flow cytometry and CD25 and Helios expression were also analyzed. The repression ability of CD4 + CD25hi cells was tested in vitro. Clinical information of pSS patients was retrospectively collected and their correlations with circulating Treg cells were analyzed. Cytokine levels in plasma were measured by ELISA and correlations with Helios+ FoxP3+ cells were also detected.
RESULTS: Circulating FoxP3+ and Helios+ FoxP3+ cells were elevated in pSS patients compared with controls. The suppression function of CD4 + CD25hi cells is not different between two groups. There are inverse correlations between Helios+ FoxP3+ percentage and ESR, IgG, IgM and ESSDAI. Anti-SSB- patients possess higher level of Helios+ FoxP3+ cells than anti-SSB+ patients. IL-6, IFNγ and IFNα levels were increased in pSS plasma and there were positive correlations between the levels of IFNγ/IFNα and percentage of Helios+ FoxP3+ cells.
CONCLUSION: Circulating Helios + FoxP3+ cells were elevated in pSS patients and may contribute to suppressing autoimmunity in pSS patients.

Entities:  

Keywords:  FoxP3; Helios; Treg; interferon; pSS

Mesh:

Substances:

Year:  2016        PMID: 27538522     DOI: 10.1080/14397595.2016.1226470

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  8 in total

1.  Down-regulation of Helios Expression in Tregs from Patients with Hypertension.

Authors:  Zhu-Yue Chen; Feng Chen; Yan-Ge Wang; Ding-Hang Wang; Li-Li Jang; Long-Xian Cheng
Journal:  Curr Med Sci       Date:  2018-03-15

Review 2.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

Review 3.  Interleukin-2 and regulatory T cells in rheumatic diseases.

Authors:  Antonios G A Kolios; George C Tsokos; David Klatzmann
Journal:  Nat Rev Rheumatol       Date:  2021-11-02       Impact factor: 20.543

4.  Decreased Helios Expression in Regulatory T Cells in Acute Coronary Syndrome.

Authors:  Lili Jiang; Feng Chen; Xiaofan Hu; Yingying Hu; Yange Wang; Wenyong Zhang; Yudong Peng; Longxian Cheng
Journal:  Dis Markers       Date:  2017-11-12       Impact factor: 3.434

Review 5.  T Cells Subsets in the Immunopathology and Treatment of Sjogren's Syndrome.

Authors:  William de Jesús Ríos-Ríos; Sorely Adelina Sosa-Luis; Honorio Torres-Aguilar
Journal:  Biomolecules       Date:  2020-11-11

6.  Gut Microbiota From Sjögren syndrome Patients Causes Decreased T Regulatory Cells in the Lymphoid Organs and Desiccation-Induced Corneal Barrier Disruption in Mice.

Authors:  Laura Schaefer; Claudia M Trujillo-Vargas; Firas S Midani; Stephen C Pflugfelder; Robert A Britton; Cintia S de Paiva
Journal:  Front Med (Lausanne)       Date:  2022-03-09

7.  Expression of ICOS in the salivary glands of patients with primary Sjogren's syndrome and its molecular mechanism.

Authors:  Ping Li; Yi Jin; Rui Zhao; Zhonghui Xue; Juan Ji
Journal:  Mol Med Rep       Date:  2022-09-30       Impact factor: 3.423

8.  Positive Anti-SSA/Ro Antibody in a Woman with SARS-CoV-2 Infection Using Immunophenotyping: A Case Report.

Authors:  Po-I Huang; Ting-Chun Lin; Feng-Cheng Liu; Yi-Jung Ho; Jeng-Wei Lu; Te-Yu Lin
Journal:  Medicina (Kaunas)       Date:  2020-10-05       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.